These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
88 related items for PubMed ID: 11519039
1. Induction of urokinase-type plasminogen activator by the anthracycline antibiotic in human RC-K8 lymphoma and H69 lung-carcinoma cells. Kiguchi T, Niiya K, Shibakura M, Miyazono T, Shinagawa K, Ishimaru F, Kiura K, Ikeda K, Nakata Y, Harada M. Int J Cancer; 2001 Sep; 93(6):792-7. PubMed ID: 11519039 [Abstract] [Full Text] [Related]
2. Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells. Niiya M, Niiya K, Kiguchi T, Shibakura M, Asaumi N, Shinagawa K, Ishimaru F, Kiura K, Ikeda K, Ueoka H, Tanimoto M. Cancer Chemother Pharmacol; 2003 Nov; 52(5):391-8. PubMed ID: 12908082 [Abstract] [Full Text] [Related]
3. Involvement of ERK1/2 and p38 MAP kinase in doxorubicin-induced uPA expression in human RC-K8 lymphoma and NCI-H69 small cell lung carcinoma cells. Niiya M, Niiya K, Shibakura M, Asaumi N, Yoshida C, Shinagawa K, Teshima T, Ishimaru F, Ikeda K, Tanimoto M. Oncology; 2004 Nov; 67(3-4):310-9. PubMed ID: 15557793 [Abstract] [Full Text] [Related]
4. Camptothecin induces urokinase-type plasminogen activator gene-expression in human RC-K8 malignant lymphoma and H69 small cell lung cancer cells. Shibakura M, Niiya K, Kiguchi T, Nakata Y, Tanimoto M. Acta Med Okayama; 2002 Oct; 56(5):223-7. PubMed ID: 12530505 [Abstract] [Full Text] [Related]
5. Induction of IL-8 and monoclyte chemoattractant protein-1 by doxorubicin in human small cell lung carcinoma cells. Shibakura M, Niiya K, Kiguchi T, Kitajima I, Niiya M, Asaumi N, Huh NH, Nakata Y, Harada M, Tanimoto M. Int J Cancer; 2003 Jan 20; 103(3):380-6. PubMed ID: 12471621 [Abstract] [Full Text] [Related]
6. Amurubicinol-induced eotaxin-3 expression in human NCI-H69 small cell lung carcinoma cells. Niiya M, Niiya K, Shibakura M, Asaumi N, Yoshida C, Tanimoto M. Oncol Rep; 2006 Mar 20; 15(3):571-6. PubMed ID: 16465414 [Abstract] [Full Text] [Related]
7. Modulation of urokinase-type plasminogen activator gene expression by inflammatory cytokines in human pre-B lymphoma cell line RC-K8. Niiya K, Shinbo M, Ozawa T, Hayakawa Y, Sakuragawa N. Thromb Haemost; 1995 Dec 20; 74(6):1511-5. PubMed ID: 8772229 [Abstract] [Full Text] [Related]
8. Cytoplasmic-nuclear shuttling of the urokinase mRNA binding protein regulates message stability. Shetty S. Mol Cell Biochem; 2002 Aug 20; 237(1-2):55-67. PubMed ID: 12236587 [Abstract] [Full Text] [Related]
9. Inhibitory effect of a synthetic prostacyclin analogue, beraprost, on urokinase-type plasminogen activator expression in RC-K8 human lymphoma cells. Nomura N, Niiya K, Shinbo M, Ozawa T, Hayakawa Y, Higashiyama K, Fujimaki M, Sakuragawa N. Thromb Haemost; 1996 Jun 20; 75(6):928-32. PubMed ID: 8822588 [Abstract] [Full Text] [Related]
10. Protein kinase activity-dependent inhibition of urokinase-type plasminogen activator gene transcription by cyclic AMP in human pre-B lymphoma cell line RC-K8. Shinbo M, Niiya K, al-Mokdad M, Hayakawa Y, Hiraga K, Fujimaki M, Sakuragawa N. Biochim Biophys Acta; 1995 Sep 21; 1268(3):293-9. PubMed ID: 7548228 [Abstract] [Full Text] [Related]
11. Expression of urokinase-type plasminogen activator, its receptor and type-1 plasminogen activator inhibitor is differently regulated by inhibitors of protein synthesis in human cancer cell lines. Lund LR. FEBS Lett; 1996 Apr 01; 383(3):139-44. PubMed ID: 8925884 [Abstract] [Full Text] [Related]
12. Protein synthesis and urokinase mRNA metabolism. Shetty S. Mol Cell Biochem; 2005 Mar 01; 271(1-2):13-22. PubMed ID: 15881651 [Abstract] [Full Text] [Related]
13. Platelet-activating factor enhances urokinase-type plasminogen activator gene expression in corneal epithelium. Tao Y, Bazan HE, Bazan NG. Invest Ophthalmol Vis Sci; 1996 Sep 01; 37(10):2037-46. PubMed ID: 8814143 [Abstract] [Full Text] [Related]
14. Urokinase-mediated posttranscriptional regulation of urokinase-receptor expression in non small cell lung carcinoma. Montuori N, Mattiello A, Mancini A, Taglialatela P, Caputi M, Rossi G, Ragno P. Int J Cancer; 2003 Jun 20; 105(3):353-60. PubMed ID: 12704669 [Abstract] [Full Text] [Related]
15. Induction of urokinase-type plasminogen activator by lipopolysaccharide in PC-3 human prostatic cancer cells. Ohta S, Niiya K, Sakuragawa N, Fuse H. Thromb Res; 2000 Mar 01; 97(5):343-7. PubMed ID: 10709910 [Abstract] [Full Text] [Related]
16. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells. Allan EH, Zeheb R, Gelehrter TD, Heaton JH, Fukumoto S, Yee JA, Martin TJ. J Cell Physiol; 1991 Oct 01; 149(1):34-43. PubMed ID: 1834680 [Abstract] [Full Text] [Related]
17. Effects of N-(4-hydroxyphenyl) retinamide on urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in prostate adenocarcinoma cell lines. Tanabe T. Hiroshima J Med Sci; 2000 Mar 01; 49(1):67-72. PubMed ID: 10824459 [Abstract] [Full Text] [Related]
18. Down-regulation of urokinase secretion from a human lymphoma cell line RC-K8 by dexamethasone without inducing plasminogen activator inhibitors. Niiya K, Nsimba M, Hayashi T, Sakuragawa N. Thromb Res; 1992 Feb 01; 65(3):311-21. PubMed ID: 1631798 [Abstract] [Full Text] [Related]
19. Protein kinase C mediates up-regulation of urokinase and its receptor in the migrating keratinocytes of wounded cultures, but urokinase is not required for movement across a substratum in vitro. Ando Y, Jensen PJ. J Cell Physiol; 1996 Jun 01; 167(3):500-11. PubMed ID: 8655604 [Abstract] [Full Text] [Related]
20. Amiloride modulates urokinase gene expression at both transcription and post-transcription levels in human colon cancer cells. Wang Y, Dang J, Liang X, Doe WF. Clin Exp Metastasis; 1995 May 01; 13(3):196-202. PubMed ID: 7750207 [Abstract] [Full Text] [Related] Page: [Next] [New Search]